Key result
Exogenous hydrogen sulfide protects against myocardial ischemia-reperfusion injury by modulating multiple signaling pathways, including JAK2/STAT3, Nrf2, SIRT1/PGC-1α, PI3K/SGK1/GSK3β, and JNK.
Why the study?
Hydrogen sulfide improves myocardial ischemia-reperfusion injury, but the underlying mechanisms and involved signaling pathways are not fully understood.
Exogenous hydrogen sulfide exerts protective effects against myocardial ischemia-reperfusion injury by modulating multiple signaling pathways, highlighting its potential as a therapeutic target.
Answers are grounded in this paper and cite their sources.
Exogenous H₂S may attenuate myocardial I/R injury via JAK2/STAT3, Nrf2, and SIRT1 pathways; leaves open the need for clinical validation before therapeutic consideration.
Ischemia/reperfusion (I/R) injury refers to the functional and structural changes in the process of blood flow recovery after ischemia. In addition to ischemia, the blood flow recovery can also lead to very harmful damage, such as the obvious cell swelling and the irreversible cell necrosis. I/R injury is related with many diseases, including myocardial I/R injury. Myocardial I/R injury refers to the aggravation of ischemic myocardial tissue injury due to sudden disorder of blood circulation. Although there are many studies on myocardial I/R injury, the exact mechanism is not fully understood. Hydrogen sulfide (H 2 S), like carbon monoxide and nitric oxide, is an important gas signal molecule. It plays an important role in many physiological and pathological processes. Recent studies indicate that H 2 S can improve myocardial I/R injury, however, its mechanism is not fully understood, especially the involved signal pathways. In this review, we summarize the related researches about the role of the signaling pathways involved in the protective effects of exogenous H 2 S on myocardial I/R injury, so as to provide theoretical reference for the future in-depth researches.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2021) conducted a review in Myocardial ischemia-reperfusion injury. Exogenous Hydrogen Sulfide was evaluated. Exogenous hydrogen sulfide protects against myocardial ischemia-reperfusion injury by modulating multiple signaling pathways, including JAK2/STAT3, Nrf2, SIRT1/PGC-1α, PI3K/SGK1/GSK3β, and JNK.
Synapse has enriched 10 related papers. Consider them for comparative context: